Literature DB >> 15897946

Molecular optical imaging: applications leading to the development of present day therapeutics.

Khalid Shah1, Ralph Weissleder.   

Abstract

A number of advances in the molecular imaging field have led to the sensing of specific molecular targets and pathways in living animals. In the optical imaging field, these include the designing of biocompatible near-infrared fluorochromes, development of targeted and activatable "smart" imaging probes, and engineering of activatable fluorescent and bioluminescent proteins. The current advances in molecular optical imaging will help in early disease diagnoses, functioning of a number of pathways and finally help speed drug discovery. In this review, we will describe the near infrared fluorescent and bioluminescence imaging modalities and how these techniques have been employed in current research. Furthermore, we will also shed some light on the use of these imaging modalities in neurotherapeutics, for example imaging different parameters of vector-mediated gene expression in glioma tumors and stem cell tracking in vivo.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15897946      PMCID: PMC1064987          DOI: 10.1602/neurorx.2.2.215

Source DB:  PubMed          Journal:  NeuroRx        ISSN: 1545-5343


  58 in total

1.  Neural precursor cells for delivery of replication-conditional HSV-1 vectors to intracerebral gliomas.

Authors:  U Herrlinger; C Woiciechowski; M Sena-Esteves; K S Aboody; A H Jacobs; N G Rainov; E Y Snyder; X O Breakefield
Journal:  Mol Ther       Date:  2000-04       Impact factor: 11.454

Review 2.  Single-photon emission computed tomography in neurotherapeutics.

Authors:  Michael D Devous
Journal:  NeuroRx       Date:  2005-04

3.  A novel heterodimeric cysteine protease is required for interleukin-1 beta processing in monocytes.

Authors:  N A Thornberry; H G Bull; J R Calaycay; K T Chapman; A D Howard; M J Kostura; D K Miller; S M Molineaux; J R Weidner; J Aunins
Journal:  Nature       Date:  1992-04-30       Impact factor: 49.962

4.  Photonic detection of bacterial pathogens in living hosts.

Authors:  C H Contag; P R Contag; J I Mullins; S D Spilman; D K Stevenson; D A Benaron
Journal:  Mol Microbiol       Date:  1995-11       Impact factor: 3.501

5.  Nitric oxide production and mitochondrial dysfunction during rat thymocyte apoptosis.

Authors:  J Bustamante; G Bersier; M Romero; R A Badin; A Boveris
Journal:  Arch Biochem Biophys       Date:  2000-04-15       Impact factor: 4.013

6.  Preparation of a cathepsin D sensitive near-infrared fluorescence probe for imaging.

Authors:  C H Tung; S Bredow; U Mahmood; R Weissleder
Journal:  Bioconjug Chem       Date:  1999 Sep-Oct       Impact factor: 4.774

7.  Broad antitumor and antiangiogenic activities of AG3340, a potent and selective MMP inhibitor undergoing advanced oncology clinical trials.

Authors:  D R Shalinsky; J Brekken; H Zou; C D McDermott; P Forsyth; D Edwards; S Margosiak; S Bender; G Truitt; A Wood; N M Varki; K Appelt
Journal:  Ann N Y Acad Sci       Date:  1999-06-30       Impact factor: 5.691

Review 8.  Proteases and their inhibitors in human brain tumours: a review.

Authors:  H K Rooprai; D McCormick
Journal:  Anticancer Res       Date:  1997 Nov-Dec       Impact factor: 2.480

9.  Preclinical evaluation and phase I clinical trial of a 99mTc-labeled synthetic polymer used in blood pool imaging.

Authors:  R J Callahan; A Bogdanov; A J Fischman; T J Brady; R Weissleder
Journal:  AJR Am J Roentgenol       Date:  1998-07       Impact factor: 3.959

10.  Real-time imaging of TRAIL-induced apoptosis of glioma tumors in vivo.

Authors:  Khalid Shah; Yi Tang; Xandra Breakefield; Ralph Weissleder
Journal:  Oncogene       Date:  2003-10-09       Impact factor: 9.867

View more
  45 in total

1.  Optical Imaging of Bacterial Infection Models.

Authors:  W Matthew Leevy; Nathan Serazin; Bradley D Smith
Journal:  Drug Discov Today Dis Models       Date:  2007

2.  Systematic calibration of an integrated x-ray and optical tomography system for preclinical radiation research.

Authors:  Yidong Yang; Ken Kang-Hsin Wang; Sohrab Eslami; Iulian I Iordachita; Michael S Patterson; John W Wong
Journal:  Med Phys       Date:  2015-04       Impact factor: 4.071

3.  Neuroimaging: anything to do with neurotherapeutics?

Authors:  Jose C Masdeu; Rohit Bakshi
Journal:  NeuroRx       Date:  2005-04

Review 4.  [Cell tracking. Principles and applications].

Authors:  J Grimm; M F Kircher; R Weissleder
Journal:  Radiologe       Date:  2007-01       Impact factor: 0.635

5.  ATP-binding cassette transporters modulate both coelenterazine- and D-luciferin-based bioluminescence imaging.

Authors:  Ruimin Huang; Jelena Vider; Inna Serganova; Ronald G Blasberg
Journal:  Mol Imaging       Date:  2011-06       Impact factor: 4.488

Review 6.  Cell tracking with optical imaging.

Authors:  Elizabeth J Sutton; Tobias D Henning; Bernd J Pichler; Christoph Bremer; Heike E Daldrup-Link
Journal:  Eur Radiol       Date:  2008-05-28       Impact factor: 5.315

7.  MBC94, a conjugable ligand for cannabinoid CB 2 receptor imaging.

Authors:  Mingfeng Bai; Michelle Sexton; Nephi Stella; Darryl J Bornhop
Journal:  Bioconjug Chem       Date:  2008-04-30       Impact factor: 4.774

Review 8.  Fluorescent imaging of cancerous tissues for targeted surgery.

Authors:  Lihong Bu; Baozhong Shen; Zhen Cheng
Journal:  Adv Drug Deliv Rev       Date:  2014-07-24       Impact factor: 15.470

Review 9.  A biological global positioning system: considerations for tracking stem cell behaviors in the whole body.

Authors:  Shengwen Calvin Li; Lisa May Ling Tachiki; Jane Luo; Brent A Dethlefs; Zhongping Chen; William G Loudon
Journal:  Stem Cell Rev Rep       Date:  2010-06       Impact factor: 5.739

10.  Imaging of angiogenesis.

Authors:  Willem J M Mulder; Arjan W Griffioen
Journal:  Angiogenesis       Date:  2010-06       Impact factor: 9.596

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.